Category Archives: U.S. Policy and Funding

In face of ongoing Ebola response challenges, WHO adapts vaccine strategy to streamline process, expand access, extend supply

By on .

“Pop-up” vaccination sites, widened eligibility for inoculations, reduced doses, and the addition of a new investigational vaccine candidate are among the strategies a panel of World Health Organization experts has recommended to reverse discouraging trends, including increased cases and continuing security threats confronting responses to the ongoing Ebola outbreak in the Democratic Republic of Congo. […]

Follows on “Pharmagate” plot: South Africa activists picket Merck office, while two drug companies leave pharmaceutical association

By on .

In the days following a leaked plan from a U.S.-based public relations firm to derail proposed patent reforms in South Africa, those involved indicated that the plan, dubbed “genocidal” by South Africa Health Minister Aaron Motsoaledi, was the product of a misunderstanding. The U.S.-based firm, Public Affairs Engagement released a statement saying that when firm […]